# Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

> **NCT05031143** · PHASE2,PHASE3 · COMPLETED · sponsor: **Benha University** · enrollment: 6 (actual)

## Conditions studied

- Vogt Koyanagi Harada Disease

## Interventions

- **DRUG:** Suprachoroidal Triamcinolone acetonide injection for serous retinal detachment in VKH disease

## Key facts

- **NCT ID:** NCT05031143
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-02-20
- **Final completion:** 2021-08-24
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05031143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05031143, "Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05031143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*